Tigecycline failed to reach 'non-inferiority' in the clinical evaluable population, which was the primary objective in that study; cure rates were 67.9% for tigecycline and 78.2% for imipenem ...

We also suggest that the category of ESBLs should be expanded. However, we recently found that the CMY-10 ESBL had higher imipenem-hydrolysing activity than OXA-23, a class D carbapenemase 7,10.

Cephalosporin, imipenem or other allergy: not recommended. Discontinue if allergic reaction or drug-induced enterocolitis syndrome occurs. Avoid in those with mononucleosis. Evaluate if diarrhea ...

Anthrax: a minimum of 5million Units/day in divided doses until cure is effected. Cephalosporin, imipenem, or other allergy: not recommended. Asthma. Electrolyte imbalance possible with rapid IV ...

Furthermore, meropenem is administered less frequently than imipenem-cilastatin and may be associated with a lower frequency of gastrointestinal adverse effects. [1] Generally, carbapenems have ...

Similarly, Klebsiella pneumoniae and Pseudomonas aeruginosa also demonstrated rising resistance, particularly to important antibiotics like piperacillin-tazobactam, imipenem, and meropenem.

Similarly, Klebsiella pneumoniae and Pseudomonas aeruginosa, two other important bacteria, also showed increasing resistance ...

New Data to be Presented at IDWeek 2024 Reinforce Merck’s Broad and Diverse Vaccines and Infectious Disease Pipeline and ...

Similarly, Klebsiella pneumoniae and Pseudomonas aeruginosa also showed increasing resistance, especially to critical antibiotics like piperacillin-tazobactam, imipenem, and meropenem.